Andrew Payne

Andrew is a partner in the Patents & Innovation team and offers expert counsel on contentious patent and regulatory matters.

Leveraging his previous experience as a medicinal chemist in the pharmaceutical industry, he is particularly focused on advising companies within the life sciences sector and is recognised by clients for his extensive industry knowledge.

Expertise

Rechtsgebiete und Gruppen

Patents Technology & Life Sciences

Handels- & Vertriebsrecht

Disputes & Investigations

Beilegung von Patent- & Know-how-Streitigkeiten

Regulatorische Beratung im Bereich Life Sciences

Erstellung & Verhandlung von Patent- & Know-how-Verträgen

IP-rechtliche Streitigkeiten

Handels- & vertriebsrechtliche Streitigkeiten

Branchen

Life Sciences & Healthcare

Chemieindustrie

Industrieunternehmen

Biotechnologie

Medizinprodukte

Life sciences start-ups and investors

Arzneimittel

CV

Since 2025 Partner, Taylor Wessing

2024 - 2025 Senior Counsel, Taylor Wessing

2020 - 2024 Senior Associate, Taylor Wessing

2015 - 2020 Associate, Taylor Wessing

2013 - 2015 Trainee Solicitor , CMS Cameron McKenna

2009 - 2013 Group Leader, Medicinal Chemistry at Eisai

2000 - 2009 Team Leader, GlaxoSmithKline

1998 - 1999 Postdoctoral Researcher, The University of Texas at Austin

2015 Admitted as a lawyer, England & Wales

2013 LPC distinction, BPP Law School

2011 GDL commendation, BPP Law School, London

1997 PhD in synthetic organic chemistry from Imperial College, London

1994 BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy

Karriere